Vanguard Group Inc Endo International PLC Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.1 - $0.75 $2.54 Million - $19 Million	-25,387,333 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.3 - $2.74 $897,033 - $8.19 Million	-2,990,113 Reduced 10.54%	25,387,333 $11.8 Million
Q1 2022 May 13, 2022	BUY	$2.13 - $3.85 $1.68 Million - $3.04 Million	789,077 Added 2.86%	28,377,446 $65.6 Million
Q4 2021 Feb 14, 2022	BUY	$3.39 - $6.76 $8.48 Million - $16.9 Million	2,501,075 Added 9.97%	27,588,369 $104 Million
Q3 2021 Nov 12, 2021	SELL	$2.1 - $5.19 $597,349 - $1.48 Million	-284,452 Reduced 1.12%	25,087,294 $81.3 Million
Q2 2021 Aug 13, 2021	BUY	$4.68 - $7.39 $119 Million - $187 Million	25,371,746 New	25,371,746 $119 Million

Ticker ENDP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 235,143,008
Market Cap $68.8M
Description
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.